Today, science writer Carl Zimmer explains the decision-making process, how long the suspension might last and the impact it could have not only in the U.S. but around the world.
Guest: Carl Zimmer, a science writer and author of the “Matter” column for The New York Times.
Yesterday
The Fight Tearing Apart Silicon Valley
For years, a debate has been simmering in Silicon Valley over the right way to build artificial intelligence. Should it be open and free for anyone to use, or should we tightly control how it’s made and who can access it? Mike Isaac, who covers technology for The New York Times, ... Show More
26m 51s
Jul 29
Israel, AIPAC and Difficult Questions for Democrats
The American Israel Public Affairs Committee, a pro-Israel lobbying group known as AIPAC, has spent a record amount of money in this year’s midterm elections to either oust or support candidates based on their support of Israel. Jonathan Mahler, a writer for The New York Times Ma ... Show More
39m 30s
Apr 2021
Coronavirus: How Scary Are the Variants?
UPDATE 4/13/21: Since this episode published, there has been some evidence linking the Johnson & Johnson coronavirus vaccine to rare blood clots. As of April 13, there were six cases in the U.S. out of more than 6.8 million doses, and one person had died. The CDC and FDA have rec ... Show More
33m 54s